Please use this identifier to cite or link to this item: http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/594
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMouri, D.
dc.contributor.authorSuman, D.
dc.contributor.authorSujan, K.B.
dc.date.accessioned2014-07-24T06:06:43Z
dc.date.accessioned2022-06-28T03:42:01Z-
dc.date.available2014-07-24T06:06:43Z
dc.date.available2022-06-28T03:42:01Z-
dc.date.issued2013-10-15
dc.identifier.urihttp://repo.lib.jfn.ac.lk/ujrr/handle/123456789/594-
dc.description.abstractAbstract Pharmaceutical industry is technologically the most advanced manufacturing industry in Bangladesh and the third largest industry in terms of contribution to government's revenue. The industry contributes about 1% of the total GDP. There are about 250 licensed pharmaceutical companies in Bangladesh. Currently a little over 100 companies are in production. According to IMS, a US-based market research firm, the retail market size is about BDT 84 billion as on 2011. Based on IMS report for the fourth quarter 2011, Square pharmaceutical holds the top market share in the retail market (18.7%), followed by Incepta and Beximco pharmaceutical. This sector fulfills 97% of the local medicine requirement. Besides, it is exporting chemicals and pharmaceutical products to global market including European market. The professional think tank, quality management, innovative ideas, government support are the key factors for the development of this sector. Hence the present study reports the profitability of two listed pharmaceutical companies of four year accounting period from 2008 to 2011. The analysis shows that average profitability indicators for Square are higher than Beximco, except gross profit ratio and operating profit ratio. On the other hand, the six other profitability indicators of Square are much higher than that of Beximco and go with the industry norm. Beximco has not been able to attain industry average net profit ratio, return on investment and return on equity, cash flow margin and cash return on assets.en_US
dc.language.isoenen_US
dc.subjectProfiten_US
dc.subjectProfitability Indicatorsen_US
dc.subjectSquare And Beximco Pharmaceutical Industryen_US
dc.titleComparison of Profitability of Listed Pharmaceutical Companies of Bangladeshen_US
dc.typeArticleen_US
Appears in Collections:Accounting

Files in This Item:
File Description SizeFormat 
Mouri, Comparison of Profitability of Listed Pharmaceutical Companies of Bangladesh.pdf251.62 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.